Our results clearly indicate that lesional skin biopsies from CTCL patients displayed increased positive staining for CD38 in comparison to the minimal staining observed in healthy human skin (Fig. 1D). This evidence concerns the gene CD38 and primary cutaneous T-cell non-Hodgkin lymphoma.